Solana Co — Director's Dealing 2017

Dec 26, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2017-12-22

Reporting Person: Walter Blane (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-22	Class A Common Stock	P	382653	$1.96	Acquired	422653	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-22	Warrant (Right to Buy)	$2.45	P	382653	Acquired	2020-12-22	Class A Common Stock (382653)	Direct

Footnotes

F1: The Class A Common Stock and the Warrant to Purchase Class A Common Stock was purchased by the Reporting Person in a private placement as a Unit. The purchase price of the Unit was $1.96.

F2: Immediately exercisable.